MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

McKesson Corp

Closed

SectorHealthcare

688.09 -0.64

Overview

Share price change

24h

Current

Min

682.07

Max

693.63

Key metrics

By Trading Economics

Income

687M

928M

Sales

1.6B

95B

P/E

Sector Avg

31.278

57.333

EPS

8.03

Dividend yield

0.41

Profit margin

0.974

Employees

45,000

EBITDA

-121M

1.4B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+4.44% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.41%

2.63%

Next Earnings

8 maj 2025

Next Dividend date

30 cze 2025

Next Ex Dividend date

30 maj 2025

Market Stats

By TradingEconomics

Market Cap

9.4B

87B

Previous open

688.73

Previous close

688.09

Technical Score

By Trading Central

Confidence

Bearish Evidence

McKesson Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 sie 2024, 14:41 UTC

Top News

Dow Gains 450 Points As Jobs Data Surprises; Warner Bros. Discovery Among Sell Signals (Live Coverage) -- IBD

8 sie 2024, 08:43 UTC

Top News

Dow Jones Futures Fall After Nvidia-Led Market Reversal; Five Earnings Movers -- IBD

Peer Comparison

Price change

McKesson Corp Forecast

Price Target

By TipRanks

4.44% upside

12 Months Forecast

Average 723 USD  4.44%

High 800 USD

Low 675 USD

Based on 12 Wall Street analysts offering 12 month price targets forMcKesson Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

9

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

674.0408 / 696.38Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Weak Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.